Massive study reveals Semaglutide's heart benefits in overweight people
NCT ID NCT07141914
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study looked at whether a once-weekly medicine called semaglutide can lower the risk of heart problems and other obesity-related health issues in people with overweight or obesity. Researchers analyzed medical records from over 285,000 people in the U.S. to see how semaglutide affected heart attacks, strokes, and other serious events. The goal was to understand the real-world benefits of this treatment for heart health and weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational
Plainsboro, New Jersey, 08536, United States
Conditions
Explore the condition pages connected to this study.